September 09, 2026 — RNews

#surgery — Wednesday, September 09, 2026 (1 items)

hot top new

← prev day next day →

0

Perioperative durvalumab plus fluorouracil, leucovorin, oxaliplatin, and docetaxel for resectable gastric and gastro-oesophageal junction adenocarcinoma (MATTERHORN): final results of overall survival and event-free survival by pathological response in a global, randomised, double-blind, placebo-controlled, multicentre, phase 3 trial. (linkinghub.elsevier.com)

Janjigian YY … Tabernero J The Lancet 2026-09-09

#clinical trial #immunotherapy #gastric cancer #chemotherapy #surgery